McKesson Corporation logo

McKesson Corporation (MCK)

Market Closed
27 Jun, 20:00
NYSE NYSE
$
725. 78
+3.78
+0.52%
$
90.8B Market Cap
17.39 P/E Ratio
2.84% Div Yield
1,932,900 Volume
25.95 Eps
$ 722
Previous Close
Day Range
720.79 736.36
Year Range
464.42 736.36
Want to track MCK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services lea.

Businesswire | 2 days ago
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 3 days ago
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Here is how McKesson (MCK) and Benitec Biopharma Limited (BNTC) have performed compared to their sector so far this year.

Zacks | 1 week ago
Here's Why McKesson (MCK) is a Strong Value Stock

Here's Why McKesson (MCK) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 week ago
Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 week ago
McKesson (MCK) Rises Higher Than Market: Key Facts

McKesson (MCK) Rises Higher Than Market: Key Facts

McKesson (MCK) concluded the recent trading session at $730.80, signifying a +1.82% move from its prior day's close.

Zacks | 2 weeks ago
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 3 weeks ago
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Is McKesson (MCK) Outperforming Other Medical Stocks This Year?

Here is how McKesson (MCK) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.

Zacks | 3 weeks ago
Why McKesson (MCK) is a Top Value Stock for the Long-Term

Why McKesson (MCK) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 month ago
Here's Why McKesson (MCK) is a Strong Momentum Stock

Here's Why McKesson (MCK) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 month ago
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock

Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 month ago
MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?

MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?

Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.

Zacks | 1 month ago
Loading...
Load More